Each 5 ml contains:
Dextromethorphan Hydrobromide I.P......... 10 mg
Phenylephrine Hydrochloride I.P................. 5 mg
Chlorpheniramine Maleate I.P...................... 2 mg
Flavoured Syrup Base………….............…….... Q.S.
Varnituss-DS Syrup is a combination of Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate.
Chlorpheniramine maleate possesses H1 antihistaminic activity and mild anticholinergic and sedative effects.Chlorpheniramine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.
Phenylephrine hydrochloride is an oral sympathomimetic amine that acts as a decongestant to respiratory tract mucous membranes. Phenylephrine hydrochlorideshrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).
Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. Dextromethorphan hydrobromide is a non-narcotic antitussive with effectiveness equal to codeine. It acts in the medulla oblongata to elevate the cough threshold.
Varnituss-DS Syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.
Patients with hypersensitivity or idiosyncrasy to any of its ingredients.
Sympathomimetic amines are contraindicated in patients with severe hypertension, severe coronary artery disease and patients on monoamine oxidase (MAO) inhibitor therapy. Antihistamines are contraindicated in patients with narrow angle glaucoma, urinary retention, peptic ulcer and during an asthma attack. Dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping the MAOI drug.
Varnituss-DS Syrup: Bottle pack of 100 ml